This 2020 secondary analysis from the VITAL trial evaluated whether daily vitamin D3 supplementation (2000 IU) reduces the risk of developing advanced cancer (metastatic or fatal) among 25,871 cancer-free adults aged 50 years and older (men) and 55 years and older (women). While there was no significant reduction in total
